SSI Diagnostica Group, a global company specializing in testing solutions for infectious diseases, has announced the acquisition of InDevR, a Colorado-based provider of advanced multiplexed solutions for vaccine testing and quality control. The addition strengthens SSID Group’s leadership in pneumococcal vaccine QC testing with nextgeneration multiplexing assays and enhanced customization capabilities. InDevR will advance the Group’s offering by adding recognized expertise in influenza and mRNA vaccine QC testing.
Read the full article: SSI Diagnostica Group Acquires US-Based Multiplexing Company to Strengthen Portfolio for Vaccine Development and QC //
Source: https://www.einpresswire.com/article/889318211/ssi-diagnostica-group-acquires-us-based-multiplexing-company-to-strengthen-portfolio-for-vaccine-development-and-qc